Cargando…
Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies
The SARS-CoV-2 virus and the COVID-19 pandemic have spread across the world and severely impacted patients living with hematological conditions. Immunocompromised patients experience rapidly progressing symptoms following COVID-19 infection and are at high risk of death. In efforts to protect the vu...
Autores principales: | Yazdani, Armand N., DeMarco, Nathaniel, Patel, Parth, Abdi, Arian, Velpuri, Prathosh, Agrawal, Devendra K., Rai, Vikrant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058097/ https://www.ncbi.nlm.nih.gov/pubmed/36992246 http://dx.doi.org/10.3390/vaccines11030662 |
Ejemplares similares
-
A Review of Hematological Complications and Treatment in COVID-19
por: Yazdani, Armand N., et al.
Publicado: (2023) -
Role of sirtuins in attenuating plaque vulnerability in atherosclerosis
por: Velpuri, Prathosh, et al.
Publicado: (2023) -
Rotator Cuff Health, Pathology, and Repair in the Perspective of Hyperlipidemia
por: Yazdani, Armand N, et al.
Publicado: (2022) -
Role of oncostatin-M in ECM remodeling and plaque vulnerability
por: Patel, Parth, et al.
Publicado: (2023) -
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)